Calcium Gluconate

Mineral/Electrolyte Calcium Salt

Dosage & Administration Guidelines

Species Route Dose Frequency Duration & Clinical Notes
Dog IV (slow) 0.5-1.5 mL/kg of 10% solution (5-15 mg/kg elemental calcium) Administer slowly over 10-30 minutes; may repeat as needed Duration: As needed based on clinical response and serum calcium levels
Notes: Monitor ECG during administration; extravasation causes tissue necrosis.
Cat IV (slow) 0.5-1.5 mL/kg of 10% solution (5-15 mg/kg elemental calcium) Administer slowly over 10-30 minutes; may repeat as needed Duration: As needed based on clinical response and serum calcium levels
Notes: Monitor ECG; cats are sensitive to rapid administration.
Horse IV (slow) 250-500 mL of 23% calcium gluconate solution (diluted in 1 L of fluids) for adult horses Administer slowly over 30-60 minutes; may repeat as needed Duration: As needed based on clinical response
Notes: Monitor heart rate and rhythm; stop if bradycardia or arrhythmias occur.
Cattle IV (slow) or SC 500 mL of 23% calcium gluconate solution (or 250-500 mL of 40% solution) IV slowly; SC administration may be used for mild cases Single dose; may repeat in 12-24 hours if needed Duration: As needed
Notes: For milk fever, administer slowly; cardiac monitoring recommended. SC injections may cause tissue irritation.
Small Ruminants IV (slow) or SC 20-50 mL of 23% calcium gluconate solution (diluted) IV slowly; or 50-100 mL SC Single dose; may repeat in 12-24 hours Duration: As needed
Notes: Use with caution; monitor for cardiac effects.
Rabbit IV (slow) or PO 10-30 mg/kg elemental calcium IV slowly; oral calcium gluconate may be used for maintenance IV as needed; PO once to twice daily Duration: As needed
Notes: Rabbits are prone to calcium metabolism issues; use cautiously.
Bird/Poultry IV (slow) or IM 10-50 mg/kg elemental calcium IV slowly; or calcium gluconate 10% solution at 0.5-1 mL/kg IM As needed Duration: As needed
Notes: Monitor for bradycardia; use with caution in small birds.
Exotic/Other IV (slow) or PO Reptiles: 10-50 mg/kg elemental calcium IV or IM; small mammals: 10-30 mg/kg IV slowly As needed Duration: As needed
Notes: Dosing varies widely; consult species-specific references.

Clinical Indications & Species Uses

General Indications
  • Emergency treatment of acute hypocalcemia
  • Adjunct in management of hyperkalemia
  • Treatment of calcium channel blocker toxicity
Dog (Canine)
  • Treatment of hypocalcemia (e.g., eclampsia, hypoparathyroidism)
  • Adjunct in treatment of hyperkalemia
  • Treatment of calcium channel blocker overdose
  • Treatment of severe hypermagnesemia
Cat (Feline)
  • Treatment of hypocalcemia (e.g., hypoparathyroidism, eclampsia)
  • Adjunct in treatment of hyperkalemia
  • Treatment of calcium channel blocker overdose
Horse (Equine)
  • Treatment of hypocalcemia (e.g., lactation tetany, transport tetany)
  • Adjunct in treatment of hyperkalemia
  • Treatment of synchronous diaphragmatic flutter (thumps)
Cattle (Bovine)
  • Treatment of clinical hypocalcemia (milk fever)
  • Treatment of hypocalcemia associated with transport tetany
  • Adjunct in treatment of hyperkalemia
Small Ruminants (Sheep / Goat)
  • Treatment of hypocalcemia (e.g., pregnancy toxemia, lactation tetany)
Rabbit & Small Mammals
  • Treatment of hypocalcemia (rarely needed)
  • Supportive therapy in cases of metabolic disorders
Avian & Poultry
  • Treatment of hypocalcemia (e.g., egg binding, nutritional secondary hyperparathyroidism)
Exotic & Other Species
  • Treatment of hypocalcemia in reptiles (e.g., metabolic bone disease)
  • Treatment of hypocalcemia in small mammals (e.g., ferrets, guinea pigs)

Pharmacology & Mechanism of Action

Drug Class: Mineral/Electrolyte | Pharmacological Group: Calcium Salt

Mechanism of Action: Calcium is essential for numerous physiological processes including muscle contraction, nerve transmission, blood coagulation, and enzyme activity. Calcium gluconate provides a source of calcium ions (Ca2+) that are required for normal cellular function. In hypocalcemia, administration of calcium gluconate restores extracellular calcium levels, thereby normalizing neuromuscular excitability, cardiac function, and other calcium-dependent processes. Calcium ions also play a role in the release of neurotransmitters and the regulation of membrane permeability.

Pharmacodynamics: Calcium gluconate increases serum calcium concentration, which in turn enhances myocardial contractility, increases peripheral vascular resistance, and improves neuromuscular function. It also participates in the coagulation cascade and is necessary for the maintenance of normal bone structure. In cases of hyperkalemia, calcium antagonizes the cardiac effects of potassium, stabilizing the myocardium. The pharmacodynamic effects are rapid when administered intravenously, with clinical improvement often seen within minutes.

⚑ Pharmacokinetics Summary

Absorption: When administered orally, calcium is absorbed from the gastrointestinal tract, but absorption is variable and dependent on vitamin D status, age, and dietary factors. Intravenous administration bypasses absorption, providing immediate availability.
Distribution: Calcium is distributed widely in the body, with approximately 99% stored in bone and teeth. The remaining 1% is present in extracellular fluid and soft tissues. It crosses the placenta and is distributed into milk.
Metabolism: Calcium is not metabolized; it exists in ionized, protein-bound, and complexed forms. The ionized fraction is physiologically active.
Excretion: Calcium is excreted primarily in the feces (unabsorbed) and urine. Renal excretion is influenced by parathyroid hormone, calcitonin, and vitamin D.
Half-Life: The half-life of calcium in the blood is short, but the overall body turnover is slow. In dogs, the half-life of intravenously administered calcium is approximately 1-2 hours.
Bioavailability: Oral bioavailability is variable, approximately 25-35% in monogastric animals, but can be higher in young animals and those with vitamin D deficiency.
Protein Binding: Approximately 40-50% of serum calcium is bound to proteins (mainly albumin), 10% is complexed with anions (citrate, phosphate), and the remaining 50% is ionized.

Available Formulations & Strengths

Injectable Solution 10% (100 mg/mL) as calcium gluconate (IV, IM, SC)
Injectable Solution 23% (230 mg/mL) as calcium gluconate (IV)
Injectable Solution 40% (400 mg/mL) as calcium gluconate (IV)
Oral Gel Various concentrations (e.g., 10% calcium gluconate gel) (PO)
Oral Tablet 500 mg, 650 mg, 1000 mg (calcium gluconate) (PO)

Contraindications & Clinical Warnings

Contraindications:
  • Hypercalcemia
  • Hypercalciuria
  • Renal calculi (calcium-containing stones)
  • Ventricular fibrillation
  • Known hypersensitivity to calcium gluconate
  • Digitalis toxicity (unless severe hyperkalemia is present and monitored)
Warnings & Clinical Precautions:
  • Administer IV slowly; rapid administration can cause cardiac arrest.
  • Extravasation can cause severe tissue necrosis; use a central line or ensure proper catheter placement.
  • Use with caution in patients with renal disease, cardiac disease, or respiratory acidosis.
  • Monitor serum calcium levels and ECG during therapy.
  • In cattle, subcutaneous administration may cause abscesses; use proper technique.
  • Do not mix with solutions containing bicarbonate, phosphate, or sulfate as precipitation may occur.
  • Use with caution in animals with hyperphosphatemia or hypermagnesemia.

Adverse Effects & Reactions

Common:

  • Local irritation at injection site
  • Tissue necrosis if extravasated
  • Mild gastrointestinal upset (oral administration)

Serious / Severe:

  • Cardiac arrhythmias (bradycardia, heart block, ventricular fibrillation)
  • Cardiac arrest
  • Hypercalcemia
  • Metabolic alkalosis
  • Tissue necrosis and sloughing

Rare:

  • Allergic reactions
  • Hypotension
  • Syncope

Key Drug Interactions

Interacting Drug / Class Clinical Effect & Mechanism Severity
Digitalis glycosides (digoxin) Increased risk of cardiac arrhythmias; calcium potentiates digitalis toxicity. High
Thiazide diuretics Increased risk of hypercalcemia due to decreased renal calcium excretion. Moderate
Corticosteroids May decrease calcium absorption and increase renal excretion, reducing effectiveness. Moderate
Tetracyclines Reduced absorption of tetracyclines when given orally with calcium. Moderate
Fluoroquinolones Reduced absorption of fluoroquinolones when given orally with calcium. Moderate
Sodium bicarbonate May cause precipitation if mixed in same IV line; also may alter ionized calcium levels. Moderate
Phosphate-containing solutions Precipitation of calcium phosphate; do not mix. High

Overdose & Toxicity Management

Signs of Toxicity:

  • Hypercalcemia
  • Depression
  • Weakness
  • Anorexia
  • Vomiting
  • Constipation
  • Polyuria and polydipsia
  • Cardiac arrhythmias
  • Coma
  • Death

Emergency Treatment Protocol: Discontinue calcium administration immediately. Treat hypercalcemia with intravenous fluids (0.9% NaCl) to promote renal excretion. Administer furosemide to enhance calciuresis. In severe cases, consider calcitonin, bisphosphonates, or glucocorticoids. Monitor ECG and serum calcium levels closely. Provide supportive care.

Food Animal Withdrawal Times

πŸ₯© Meat: 0 daysπŸ₯› Milk: 0 daysπŸ₯š Eggs: 0 days

Calcium gluconate is generally considered to have zero withdrawal times in food animals when used according to label. However, extra-label use may require extended withdrawal periods; consult a veterinarian.

Storage, Handling & Regulatory Information

Storage Temperature: Store at controlled room temperature (15-30Β°C). Protect from freezing.

Handling & Special Conditions: Do not store in direct sunlight. Keep container tightly closed. Avoid excessive heat.

Dispensing Status: Prescription Required (Rx Only)

Approval Status: Calcium gluconate is FDA-approved for use in cattle, horses, dogs, and cats. Other species are extra-label.

Extra-Label (Off-Label) Use: In the US, extra-label use of calcium gluconate in food animals is permitted under AMDUCA with veterinary oversight, but withdrawal times must be extended as determined by the veterinarian. In the EU, similar regulations apply under Cascade.

Clinical Pearls & Practice Notes

πŸ’‘ Clinical Insights: Calcium gluconate is a critical emergency drug for the treatment of hypocalcemia, particularly in dairy cattle (milk fever) and small animals (eclampsia). It is also used as an antidote for hyperkalemia and calcium channel blocker toxicity. When administering intravenously, always give slowly and monitor cardiac function. Extravasation is a serious complication; ensure proper IV catheter placement. In food animals, calcium gluconate is often used at higher concentrations (23% or 40%) and may be given subcutaneously for mild cases, but IV administration is preferred for severe hypocalcemia. Always calculate the dose based on elemental calcium content (10% solution = 100 mg/mL calcium gluconate, which provides approximately 9.3 mg/mL elemental calcium). Calcium gluconate is generally safe when used appropriately, but overdose can be fatal. Regular monitoring of serum calcium levels is recommended during prolonged therapy.

References & Literature

  • πŸ“š Plumb's Veterinary Drug Handbook
  • πŸ“š Papich Veterinary Pharmacology and Therapeutics
  • πŸ“š Compendium of Veterinary Products (CVP)